Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Apr 7, 2025; 31(13): 104046
Published online Apr 7, 2025. doi: 10.3748/wjg.v31.i13.104046
Table 2 Baseline characteristics of patients undergoing laparoscopic pancreaticoduodenectomy and laparoscopic duodenum-preserving total pancreatic head resection, n (%)
Variables
Overall (n = 59)
LPD group (n = 35)
LDPPHRt group (n = 24)
P value
Sex0.628
    Male20 (33.9)11 (31.4)9 (37.5)
    Female39 (66.1)24 (68.6)15 (62.5)
Age (year)53 (40, 63)56 (46, 63)52 (35, 61)0.407
Weight (kg)57.1 ± 9.859.00 ± 10.3854.4 ± 8.40.078
BMI (kg/m2)21.3 ± 2.921.9 ± 3.220.4 ± 2.20.042
Abdominal surgery history23 (39.0)12 (34.3)11 (45.8)0.372
ASA classification0.181
    I2 (3.4)1 (2.9)1 (4.2)
    II34 (57.6)17 (48.6)17 (70.8)
    III23 (39.0)17 (48.6)6 (25.0)
Consistency of pancreas0.334
Soft41 (69.5)26 (74.3)15 (62.5)
Firm or hard18 (30.5) 9 (25.7)9 (37.5)
AST (U/L)17 [14.0, 22.0]17 [14.0, 25.0]16 [14.0, 19.75]0.104
ALT (U/L)13 [10.0, 25.0]13 [11.0, 38.0]11.5 [9.25, 19.25]0.042
AST/ALT1.3 [0.9, 2.0]1.3 [0.7, 1.5]1.4 [1.1, 1.6]0.083
FIB-4 index1.2 [0.7, 1.8]1.3 [0.8, 1.8]1.1 [0.7, 1.8]0.396
TC (mmol/L)3.89 [3.44, 4.49]3.95 [3.44, 4.50]3.86 [3.38, 4.32]0.611
TG (mmol/L)0.96 [0.71, 1.40]0.96 [0.71, 1.57]0.97 [0.67, 1.37]0.835
Albumin (g/L)40.5 ± 3.340.0 ± 3.241.4 ± 3.30.077
Random blood glucose (mmol/L)5.1 [4.7, 5.7]5.4 [4.8, 6.2]5.0 [4.5, 5.5]0.071
Uric acid (μmol/L)286 [250, 357]300 [250, 364]271 [249, 323]0.343
Liver-to-spleen CT attenuation differential (HU)3.8 [2.2, 7.9]3.8 [2.3, 7.9]3.4 [1.4, 7.9]0.502
Liver-to-spleen CT attenuation ratio1.03 [1.02, 1.06]1.03 [1.02, 1.05]1.02 [1.01, 1.06]0.422